Firm Overview

Systematica Investments launched in January 2015 after a decade of experience within BlueCrest Capital Management, to focus on rigorously applying science and technology to the investment process. The firm was founded by Leda Braga and manages approximately $10.2bn (as at 1 March 2016) across a number of futures and equity based strategies. The philosophy of the firm is one of innovation, excellence in research and a commitment to fostering strong alignment with investors. Systematica Investments has a global presence with offices in Jersey, Geneva, London, New York and Singapore.

Our MissionTo create wealth by applying science and technology
  • Excellence

  • Innovation

  • Team Work

  • Pride

  • Fun

Team Culture & Investment Philosophy

  • The pursuit of excellence permeates all of Systematica’s activities
  • Collaborative working environment within and across all functional teams
  • Rigorous review by peers throughout the research and development cycle
  • We aim to be systematic investors and avoid intervening with the model
 - our interaction with the model is via the research process
  • Significant investment in technology 
– our trend following strategy is currently running on the third generation of our proprietary trading platform
  • All aspects of the investment process and platform are subject to continuous research 
and improvement

Management Team

  • Leda Braga

    CEO

    Former President and Head of Systematic Trading, BlueCrest. Leda joined BlueCrest from Cygnifi Derivatives Services (a J.P. Morgan spin-off) in October 2001. At Cygnifi she formed part of the management team and was head of its Valuation Service. Prior to Cygnifi, Leda spent nearly seven years at J.P. Morgan as a Quantitative Analyst in the derivatives research team. Her past experience includes modelling of interest rate exotics, FX/interest rate hybrid instruments and equity derivatives. She holds a PhD in Engineering from Imperial College London, where she worked as a lecturer and led research projects for over three years prior to joining J.P. Morgan.

  • Matt Kilsby

    Chief Operating Officer

    Former Head of Systematic Implementation, BlueCrest. Matt joined BlueCrest in January 2013 having previously been at UBS where he was Managing Director, EMEA Head of Equities IT. Prior to his time at UBS, Matt held roles leading software development and business strategy, within a high frequency trading start-up firm. Previously he had spent four years at Citadel, holding various senior roles including Head of European Technology. Matt began his career at Goldman Sachs, where he spent ten years, in various technology roles covering risk, wealth management and fixed income trading. He has a BEng in Software Engineering from University of Manchester (UMIST).

  • Paul Rouse

    Chief Financial Officer

    Former Head of Product Control, BlueCrest. Paul joined BlueCrest in 2006. In 8 years he covered all functional areas and all funds within the BlueCrest Product Control function having previously been a Product Control manager at Goldman Sachs for 3 years focussing on equity derivatives trading. Paul trained as a Chartered Accountant at Ernst and Young within their Corporate Tax business, qualifying as an ACA in Jan 2004. He holds a BSc (Hons) in Marine Biology from Newcastle University.

  • David Kitson

    Chief Investment Officer

    Former Product Manager, BlueCrest. David joined BlueCrest in January 2011. Prior to BlueCrest, David was a Managing Director at J.P. Morgan where he worked from 1992 to 2010. He joined J.P. Morgan’s Quantitative Research Department after completing his PhD. David held many trading and management positions during his tenure at J.P. Morgan including: Head Trader Foreign Exchange Options, Head of Energy and Head Trader Fixed Income Hybrids. In 2007 he moved from trading management to focus his efforts solely on proprietary trading. David holds a PhD in Theoretical Physics from Manchester University.

  • Jean-Pierre Selvatico

    Head of Trading and Counterparty Management

    Former Head of Hedge Funds at Pictet Alternative Advisors, Jean-Pierre Selvatico joined Systematica in January 2017 as Head of Trading and Counterparty Management. Jean-Pierre worked for Pictet Alternative Advisors for 7 years where he acted as CIO of the hedge fund division, responsible for selecting and investing in external hedge funds across all strategies. Prior to joining Pictet, Jean-Pierre was a managing director at Barclays Capital in London in charge of the European interest rate option desk. He started his career in 1993 at JP Morgan London as a quantitative researcher and then moved to the interest rate swaps market-making desk. From 1997 to 2000 he managed the Dollar option desk for JP Morgan in New-York. Prior to joining Barclays Capital in 2004, he worked at Credit Suisse First Boston in London from 2002 to 2004.Jean-Pierre graduated from Ecole Polytechnique in Paris and later from Ecole Nationale de la Statistique et de l'Administration Economique (ENSAE).

  • Pawel Lewicki

    Head of Research

    Former Head of Systematic Research, BlueCrest. Pawel joined BlueCrest in January 2010 from Barclays Capital where, as a Managing Director, he acted as Global Head of Quantitative Analytics for three years. Prior to that, Pawel was a Managing Director at J.P. Morgan, where he worked for 12 years in the Derivatives Research and Strategy Group. Before starting his career in finance, Pawel led research work in statistical signal processing for Schlumberger in the US. Pawel has a PhD in Applied Mathematics from New York University's Courant Institute, with a specialisation in probability theory and random media. He holds a US patent in data analysis methods.

  • Ben Dixon

    General Counsel

    Former Legal Counsel, BlueCrest. Before joining Systematica, Ben previously worked for BlueCrest Capital for 9 years as Legal Counsel. He joined BlueCrest in 2005 from McDermott, Will & Emery, where he was an Associate Solicitor in the corporate department. He qualified as a solicitor in September 2003 with Allen & Overy in London, where he worked in the corporate and mergers & acquisitions department. Ben graduated from Queens' College, Cambridge University in 2000 and holds a BA (Hons) Law/MA (Cantab) Law. He undertook his LPC at Nottingham Law School in 2001.

  • Declan Ryan

    Head of Investor Relations

    Former Co-Head of Investor Relations North America, BlueCrest. Prior to joining BlueCrest, Declan was an Executive Director at UBS where he served as Head of Investor Relations in North America for UBS O’Connor, a multi-strategy hedge fund group. Before UBS Declan was a Vice President at JPMorgan Alternative Asset Management where he was responsible for business development and client relations. Declan is a CFA Charterholder and holds a Bachelor of Business and Law from University College Dublin (1995).

Investment Team

The investment team is organised functionally across three lines; Research, Technology and Trading with the Product Management team providing strategic oversight, coordination and development direction.